KOSDAQ · Healthcare · ₩167B
₩7410.00%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 0.0% · as of 26.09.11
Among 36 신약 개발 peers
Quarterly Revenue Growth
“검사에서 남는 몫은 늘었지만 본격 회복은 더 기다려야 해요.”
In the company's words · 2026 2분기 filing